SEC Filing Summary: Cerecor Inc. (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cerecor Inc. on November 23, 2015. The report discloses the closing of a partial exercise of the over-allotment option related to the Company's initial public offering (IPO), which originally closed on October 20, 2015. The Company's securities trade on the NASDAQ Capital Market under the symbols "CERC" (common stock), "CERCW" (Class A warrants), and "CERCZ" (Class B warrants).
Key Financial Metrics
The filing details a specific capital raise event rather than periodic financial performance. The transaction involved the issuance of:
- Common Stock: 20,000 shares at $6.49 per share.
- Class A Warrants: 551,900 warrants (1:1 ratio) at $0.005 per warrant.
- Class B Warrants: 551,900 warrants (1:0.5 ratio) at $0.005 per warrant.
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity metrics.
Material Changes
The primary material change is the increase in outstanding shares and warrants resulting from the partial over-allotment exercise. As of the filing date, the underwriters' over-allotment option remains exercisable until November 27, 2015, for an additional 580,000 shares of common stock, 48,100 Class A warrants, and 48,100 Class B warrants.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook. It includes a standard disclaimer stating that the report does not constitute an offer to sell or a solicitation of an offer to buy the securities described, nor shall there be any sale in jurisdictions where such offer would be unlawful prior to registration.
Key Facts for Investor Verification
- Verify the total number of shares outstanding following this partial over-allotment exercise.
- Confirm the final status of the remaining over-allotment option (580,000 shares) by the expiration date of November 27, 2015.
- Review the IPO prospectus for the full terms of the Class A and Class B warrants, including exercise prices and expiration dates, which are not detailed in this 8-K.
- Note that the company name in the metadata (Avalo Therapeutics) differs from the registrant in the filing (Cerecor Inc.); verify if a name change or acquisition has occurred since this 2015 filing.